Considerable data support the idea that forkhead box O1 (Foxo1) drives the liver transcriptional program during fasting and is then inhibited by thymoma viral proto-oncogene 1 (Akt) after feeding. Here we show that mice with hepatic deletion of Akt1 and Akt2 were glucose intolerant, insulin resistant and defective in their transcriptional response to feeding in the liver. These defects were normalized with concomitant liver-specific deletion of Foxo1. Notably, in the absence of both Akt and Foxo1, mice adapted appropriately to both the fasted and fed state, and insulin suppressed hepatic glucose production normally. A gene expression analysis revealed that deletion of Akt in liver led to the constitutive activation of Foxo1-dependent gene expression, but again, concomitant ablation of Foxo1 restored postprandial regulation, preventing the inhibition of the metabolic response to nutrient intake caused by deletion of Akt. These results are inconsistent with the canonical model of hepatic metabolism in which Akt is an obligate intermediate for proper insulin signaling. Rather, they show that a major role of hepatic Akt is to restrain the activity of Foxo1 and that in the absence of Foxo1, Akt is largely dispensable for insulin-and nutrient-mediated hepatic metabolic regulation in vivo. For example, liver-specific chronic ablation of Foxo1 results in a mild improvement in insulin sensitivity, and hypoglycemia occurs only after prolonged fasting in adult mice with this ablation. In addition, in these mice, the expression of Irs2, G6pc, Pck1, Ppargc1a and Igfbp1 is lower as a result of the ablation, but there is little or no change in the expression of Gck (glucokinase) or the lipogenic genes 30, 31 . Perhaps one reason for the confusion regarding the physiological role of Foxo1 is that much of the information about its functions in hepatic metabolism has been obtained from insulinresistant livers, in which unchecked Foxo1 activation results in profound metabolic abnormalities in gluconeogenesis as well as in lipid metabolism and glycogen storage 6, 30 . Antagonizing or reducing hepatic Foxo1 activity in insulin-resistant mice greatly improves their glucose tolerance and insulin responsiveness 6, 22, 27, 30, 32, 33 . Notable examples of this are the findings from studies using Insr (insulin receptor) knockout mice or mice with liver-specific knockout of both Irs1 and Irs2, in which concomitant deletion of hepatic Foxo1 reversed much of the metabolic defect resulting from the knockouts 6, 30 .
a r t i c l e s
Eukaryotic organisms have developed mechanisms of varying complexity to deal with periods of starvation and nutritional abundance. In mammals, the obligate requirement for at least some simple carbohydrate at all times is fulfilled during fasting by the liver, which initially breaks down glycogen before transitioning to gluconeogenesis as a means of releasing glucose into the circulation. Just as phylogenetically conserved adaptations to fasting are crucial for survival, a complex interplay of hormonal, neural and nutritional signals drive the coordinated response to feeding. Ultimately, the ability of an organism to survive dietary deprivation depends on the effectiveness of its nutrient storage during the postprandial state, as well as the mobilization of those nutrients during periods of energy deficits.
Almost since its discovery, researchers have recognized the importance of insulin to the metabolic transition that accompanies feeding 1 . In recent years, there has emerged a clear picture of the insulin signaling pathway, beginning with insulin's interaction with its receptor, which phosphorylates the scaffolding protein family insulin-receptor substrate (Irs). This initiates a linear signaling cascade that culminates in the phosphorylation of Akt protein kinases [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Once activated, Akt kinases use several distinct downstream pathways to modulate metabolism. One pathway branch involves phosphorylation and inactivation of the tuberous sclerosis 1 (Tsc1)-Tsc2 complex, leading to activation of the mammalian target of rapamycin complex 1 (mTorc1) and its immediate downstream target, p70 S6 kinase, which promotes protein translation and cell growth 11, 12 . Activation of mTorc1 correlates with and is probably necessary for insulin-induced accumulation of the sterol regulatory element binding transcription factor 1 (Srebf1, also known as Srebp1c), which drives the lipogenic program [12] [13] [14] [15] [16] [17] . On another pathway branch, Akt phosphorylates and inactivates glycogen synthase kinase 3 (Gsk3α and Gsk3β), resulting in glycogen synthase activation and glycogen accumulation, as well as reduced phosphorylation and degradation of Srebf1 (ref. 18 ). On the third pathway branch, Akt phosphorylates and inactivates the Foxo family of transcription factors, which is responsible for the decrease during insulin signaling in the transcription of genes encoding gluconeogenic enzymes [19] [20] [21] [22] .
In liver, Foxo1 collaborates with the co-activators peroxisome proliferator-activated receptor γ co-activator 1α (Ppargc1a) and Creb-regulated transcription co-activator 2 (Crtc2) to coordinately increase the expression of the genes G6pc (glucose-6-phosphatase, catalytic subunit) and Pck1 (cytosolic phosphoenolpyruvate carboxykinase 1) [23] [24] [25] . It is generally accepted that Foxo1 is active during fasting and inactivated by Akt-mediated phosphorylation after feeding and that the antagonism of Foxo1 by Akt is the predominant mechanism by which insulin suppresses hepatic glucose output after a meal 1, [25] [26] [27] [28] . Data contributed by a number of laboratories in support of this model include the following observations: (i) insulin induces the phosphorylation and activation of Akt after feeding; (ii) activated Akt phosphorylates Foxo1 at Thr24, Ser253 and Ser316 of the mouse protein; (iii) phosphorylated Foxo1 translocates out of the nucleus; and (iv) transcription of Foxo1-dependent genes, such as G6pc, Pck1, Igfbp1 (insulin-like growth factor binding protein 1) and Irs2, is reduced [19] [20] [21] [24] [25] [26] 29 . Nonetheless, there are several gaps and apparent contradictions in the current knowledge about Foxo1.
For example, liver-specific chronic ablation of Foxo1 results in a mild improvement in insulin sensitivity, and hypoglycemia occurs only after prolonged fasting in adult mice with this ablation. In addition, in these mice, the expression of Irs2, G6pc, Pck1, Ppargc1a and Igfbp1 is lower as a result of the ablation, but there is little or no change in the expression of Gck (glucokinase) or the lipogenic genes 30, 31 . Perhaps one reason for the confusion regarding the physiological role of Foxo1 is that much of the information about its functions in hepatic metabolism has been obtained from insulinresistant livers, in which unchecked Foxo1 activation results in profound metabolic abnormalities in gluconeogenesis as well as in lipid metabolism and glycogen storage 6, 30 . Antagonizing or reducing hepatic Foxo1 activity in insulin-resistant mice greatly improves their glucose tolerance and insulin responsiveness 6, 22, 27, 30, 32, 33 . Notable examples of this are the findings from studies using Insr (insulin receptor) knockout mice or mice with liver-specific knockout of both Irs1 and Irs2, in which concomitant deletion of hepatic Foxo1 reversed much of the metabolic defect resulting from the knockouts 6, 30 .
Current data support a model in which Akt is an obligate insulin-signaling intermediate that suppresses the expression of genes encoding gluconeogenic enzymes through inhibition of Foxo1, which is active during fasting. In this study, we test an alternative interpretation of these data. We found that inhibition of Foxo1 is a major role of hepatic Akt, such that once Foxo1 is removed, most of the normal metabolic regulation is maintained in the absence of liver Akt. These data refute the notion that insulin signals through hepatic Akt under all conditions in vivo, and, rather, suggest an alternative, previously unrecognized mechanism through which liver responds to nutrients and insulin signaling.
RESULTS
Liver-specific deletion of Akt1 in Akt2-null mice There are three isoforms of Akt, and in mouse liver Akt2 accounts for 84% of the total Akt protein content, with the remainder being Akt1; there are no detectable amounts of Akt3 in mouse liver 34 . Wholebody Akt2-null mice (Akt2 -/-) have a mildly diabetic phenotype on a mixed 129-C57BL/6J background 4 . A plausible explanation for the relative mildness of this glucose intolerance is that residual Akt1 in the livers of the Akt2 -/-mice partially rescues their insulin responsiveness. To address this issue, we bred Akt1 loxP/loxP ; Akt2 -/-mice to Afp-Cre mice, which express Cre recombinase specifically in liver 35 , to generate mice with systemic Akt2 deletion and liver-specific Akt1 deletion. Akt1 deletion (Cre + ) in the liver of Akt2 -/-mice led to severe hyperglycemia as compared to both wild-type (data not shown) and Akt2 -/-(Cre -) mice (Fig. 1a) . In addition, the Akt2 -/-mice with liverspecific Akt1 deletion lacked Gck protein in their liver and had higher concentrations of Igfbp1 protein in both their liver and serum than Akt2 -/-mice without the Akt1 deletion (Fig. 1b) . Because Igfbp1 is a major target gene for Foxo1 (ref. 6) , these data suggested an activation of Foxo1in the livers from the Akt2 -/-mice with the liver-specific Akt1 deletion.
Insulin signaling in Akt1, Akt2 double-knockout livers To understand in more detail the hepatic functions of Akt kinases without the complications of peripheral insulin resistance 4 , we injected Akt2 loxP/loxP mice and Akt1 loxP/loxP ; Akt2 loxP/loxP mice with adeno-associated virus expressing Cre recombinase under the control of the thyroxine-binding globulin (Tbg) promoter (AAV-TbgCre), which led to the liver-specific deletion of Akt2 alone (referred to here as 2LKO) and of both Akt1 and Akt2 (DLKO), respectively (Fig. 2a,b) . Akt2 loxP/loxP (2LWT) and Akt1 loxP/loxP ; Akt2 loxP/loxP (DLWT) mice injected with the virus expressing GFP instead of Cre served as controls. The expression of GFP or Cre in wild-type livers using this viral delivery system did not result in any detectable changes in carbohydrate or lipid metabolism (data not shown).
A western blot analysis confirmed the efficient deletion of Akt1 and Akt2 in hepatocytes from the DLKO mice 2 weeks after virus injection (Fig. 2a) . There was no change in the concentration of Akt1 or Akt2 protein in the muscle or adipose tissue of these mice at this time point. To investigate the effect of removing Akt kinases on hepatic insulin signaling, we fasted all groups of mice overnight and then fed them normal chow. After feeding, indices of insulin-dependent signaling, such as increases in the phosphorylation of ribosomal protein S6 and Gsk3α and Gsk3β and a decrease in Igfbp1 protein concentration, were not different between the 2LKO livers and the 2LWT livers (Fig. 2b) . Even though Akt2 makes up the majority of Akt protein in the liver, postprandial phosphorylation of Akt at Ser473 was stimulated to the same extent in 2LKO livers as in the 2LWT livers. This is probably a reflection of the low stoichiometry of Akt phosphorylation in the prandial state and the ability of Akt1 to compensate for a deficiency in Akt2. To test this possibility, we injected a supraphysiological dose of insulin into 2LWT and 2LKO mice. Twenty minutes after insulin injection, Akt phosphorylation at Ser473 was notably lower in the 2LKO livers compared to the 2LWT control livers ( Supplementary  Fig. 1 ). These data indicate that chow feeding led to the phosphorylation of only a small fraction (<4%) of the endogenous Akt.
In DLKO livers, the amount of feeding-induced phosphorylation of Akt at Ser473 was virtually undetectable (Fig. 2b) . S6 phosphorylation was diminished in DLKO livers, but phosphorylation of Gsk3α and Gsk3β was preserved. The normal phosphorylation of Gsk3α and Gsk3β probably reflected higher expression in the DLKO livers than DLWT livers of Sgk1 (serum-glucocorticoid regulated kinase 1) (Fig. 2c) , which is known to phosphorylate Gsk3α and Gsk3β in response to insulin 36 . Mitogen-activated protein kinase 1 (Erk2) kinases, which are downstream of the insulin receptor and located in parallel to Akt in a separate pathway, were activated normally in DLKO livers after feeding (Fig. 2b) .
Expression of the Foxo1-regulated genes in DLKO livers
The Foxo1 transcription factor is a major target of Akt. Expression of Irs2, a direct Foxo1 target gene 6 , was significantly higher in DLKO compared to control (2LWT and DLWT) livers (Fig. 2c) . Other Foxo1-dependent genes, such as Ppargc1a and Igfbp1 (refs. [37] [38] [39] , were also induced in the DLKO livers (Fig. 2c) . The expression of Gck, a gene npg a r t i c l e s suppressed by Foxo1 (refs. 6, 26, 40) , was markedly lower in DLKO livers compared to control livers. Expression of G6pc and Pck1 in the DLKO livers was not different from that in the control livers during fasting, but the normal suppression of these genes seen in the control mice after feeding was lost in the DLKO livers (Fig. 2c) . Consistent with altered gene expression, Igfbp1 protein was substantially more abundant in both the liver and serum after deletion of both Akt1 and Akt2 from liver in DLKO mice, and Gck protein was almost undetectable in these mice (Fig. 2b) . Taken together, these data strongly indicate that activation of Foxo1 is a key consequence of deleting Akt from the liver.
Metabolic abnormalities in DLKO mice
Two weeks after virus injection, the fasting blood glucose concentration in the DLKO mice tended to be higher than in the control mice, but the difference between the groups did not reach statistical significance (Fig. 3a) . However, blood glucose concentration after overnight fast and then 4 h after feeding was significantly higher in DLKO mice compared to controls (Fig. 3b) . The glycogen content was considerably lower in the DLKO livers 4 h after feeding compared to the control livers ( Supplementary Fig. 2 ). Three weeks after virus injection, blood glucose concentrations in DLKO mice during both fasting and re-feeding were higher than in control mice (data not shown). To minimize the potential secondary effects resulting from hyperglycemia, we performed subsequent experiments 2 weeks after virus injection. When challenged with glucose, the DLKO mice were glucose intolerant (Fig. 3c) . The concentration of serum insulin during both fasting and the glucose tolerance test were higher in DLKO mice than in control mice (Fig. 3d) , suggesting insulin resistance. We confirmed this resistance through the use of a hyperinsulinemic-euglycemic clamp (Fig. 3e) , which revealed a much lower glucose infusion rate compared to control mice and a failure to suppress liver glucose output by insulin in the DLKO mice. The glucose disposal rate in DLKO mice was also lower than that in control mice ( Fig. 3e and Supplementary  Fig. 3 ), indicating that the DLKO mice developed peripheral insulin resistance as a result of the deletion of Akt1 and Akt2 in their liver. In most of these assays, the 2LKO mice were indistinguishable from the control mice, although there was a small but significant blunting of postprandial glycogen storage (P < 0.05) (Supplementary Fig. 2 ) and insulin-dependent suppression of hepatic glucose output in these mice (Fig. 3f) .
Hepatic Foxo1 deletion in wild-type and DLKO mice Because Akt suppresses Foxo1 activity, if activation of Foxo1 is responsible for the glucose intolerance and altered gene expression seen in DLKO mice, deletion of Foxo1 should largely reverse the abnormal metabolism in these mice. Mice with liver-specific chronic deletion of Foxo1 developed hypoglycemia after prolonged fasting 30, 31 . To assess the effect of acute removal of Foxo1 from the liver (Foxo1 -/-), we injected the Foxo1 loxP/loxP mice 30 with AAV-Tbg-Cre. The efficient deletion of Foxo1 was confirmed by the observed lower mRNA level and protein concentration after injection of the virus ( Supplementary  Fig. 4a,b) . These mice showed hypoglycemia after overnight fasting but then showed euglycemia after feeding ( Supplementary Fig. 4c,d ).
To investigate whether unrestrained activation of Foxo1 in the DLKO livers was indeed responsible for the metabolic disturbances in the DLKO mice, we deleted Foxo1 in the DLKO livers. Injection of AAVTbg-Cre into Akt1 loxP/loxP ; Akt2 loxP/loxP ; Foxo1 loxP/loxP mice resulted in the liver-specific recombination of all three genes (TLKO), as confirmed by western blotting (Fig. 4a ). Mice injected with virus expressing GFP instead of Cre served as controls (LWT). In the TLKO mice, the fasting blood glucose concentration was indistinguishable from that seen in the control mice (Fig. 4b) . The hyperglycemia present 4 h after feeding in the DLKO mice was normalized in the TLKO mice (Fig. 4c) . Deletion of Foxo1 also reversed the glucose intolerance and fasting hyperinsulinemia seen in the DLKO mice (Fig. 4d,e ). In contrast, liver glycogen concentrations 4 h after feeding remained lower in TLKO livers than control livers ( Supplementary Fig. 5 ), despite the fact that the Foxo1 deletion in the TKLO mice normalized the suppressed glucose-glucose-6-phosphate cycling seen in the DLKO livers (Supplementary Fig. 6 ).
In hepatocytes from both DLKO and TLKO mice, we did not detect phosphorylation of Akt at Ser473, Foxo1 at Thr24 or Foxo4 at Thr28 (Fig. 4a) . In the livers of control LWT fasted mice, insulin injection quickly induced robust phosphorylation of Akt, S6 and direct Akt substrates such as Foxo1, Tsc2 (ref. 41 
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Relative expression G6pc (Akt1s1, also known as Pras40) 42 ( Fig. 4f) . These phosphorylation events were either lost or markedly blunted in both DLKO and TLKO livers. In line with these observations, we detected no compensatory increase in Akt3 concentration in either the DLKO or the TLKO livers ( Supplementary Fig. 7 ). Phosphorylation of Gsk3α and Gsk3β was maintained in both DLKO and TLKO livers, though to lesser extent in the latter group (Fig. 4f) . Similar to insulin injection, feeding elicited enhanced phosphorylation of Akt at Ser473, Foxo1 at Ser253 and Thr24 and Akt1s1 in the control livers but not in the DLKO or TLKO livers (Fig. 4g) . Phosphorylation of Gsk3α and Gsk3β was induced after feeding in the DLKO but not the TLKO livers, correlating with higher expression of Sgk1 in the DLKO livers and the normalization of this expression in the TLKO livers (Supplementary Fig. 8 ). In the TLKO livers, Gck protein concentrations were partially normalized, and the Igfbp1 protein concentration was restored to the same level as that seen in the control mice (Fig. 4g) , which is consistent with Foxo1 activity being considerably higher in the DLKO than the control or TLKO livers.
Normal response to feeding and insulin in TLKO livers
The above data are consistent with the prevailing view that Akt drives the adaptation to the fed state by suppressing Foxo1-dependent gene expression such that defects resulting from ablation of Akt signaling are reversed by the concomitant removal of Foxo1 (Fig. 4) . Analogous data have been interpreted as reflecting a linear pathway in which Foxo1 promotes the transcription of the genes encoding rate-determining gluconeogenic enzymes. However, a plausible alternative view that is compatible with both previously published data as well as our new data is that Foxo1 also represses a parallel, Akt-independent signaling pathway that controls the prandial response (Fig. 5a) . To distinguish between these models, we measured the expression of key metabolic genes in npg a r t i c l e s or after feeding, and their regulation from fasting to feeding was largely normal (Fig. 5b) .
As shown in Figure 5c , in LWT control mice, feeding induced the expected regulation of gene expression, as indicated by decreases in the expression of Ppargc1a, Igfbp1, Pck1 and G6pc and increases in the expression of Srebf1, Hmgcr (3-hydroxy-3-methylglutarylCoA reductase), Hmgcs (3-hydroxy-3-methylglutaryl-CoA synthase) and Gck. In DLKO livers, the expression of these genes under the fasted and the fed states resembled that of the control livers under the fasted state, although the expression of Ppargc1a, Igfbp1, Srebf1 and Hmgcr continued to be regulated to some extent by feeding in DLKO livers. Of note, for most of the genes tested, the TLKO livers responded to feeding in a manner that was indistinguishable from the control livers, indicating that the regulation of these genes in these livers was through a mechanism that was independent of Akt and Foxo1. These data support a permissive role for Akt-mediated suppression of Foxo1 rather than, or in addition to, Akt acting as an obligate intermediate in the postprandial signaling pathway.
To assess the scope of the effects of Foxo1 on the expression of metabolically responsive genes, we subjected mRNA from LWT, DLKO and TLKO livers to a genome-wide expression analysis. We classified 688 genes as being 'metabolically responsive' , which we defined as having an at least twofold change in expression from fasting to feeding in control livers (Supplementary Table 1) . Of these genes, 298 showed altered expression in the DLKO livers compared to control livers 4 h after feeding (Supplementary Table 2 ), indicating that Akt was crucial to their regulation. As shown in the heat map in Supplementary Figure 9 , for most of the 298 metabolically regulated genes, their expression in the DLKO livers in both the fasted and fed state was similar to the fasted state in the control livers (compare columns 3 and 4 to column 1), and the dysregulated gene expression seen in the DLKO livers was largely reversed in the TLKO livers (compare columns 1 and 2 to columns 5 and 6). Whether expression was induced or suppressed in the control livers after feeding, the disruption in regulation in the DLKO livers was at least partially reversed and appropriate postprandial adaptation was reestablished in the TLKO livers. Given that an analogous experiment has previously been performed with liver-specific Irs1 -/-; Irs2 -/-mice 6 , we compared the ratio of gene expression in liver-specific Irs1 -/-; Irs2 -/-(ref. 6) and Akt1 -/-; Akt2 -/-knockout mice to wild-type mice in the fasted and fed states (Supplementary Fig. 10 ). There was a notable concurrence between the changes resulting from deletion of the two Irs genes and deletion of the two Akt genes in liver. The mostly normal switch in gene expression from the fasted to fed state in the TLKO and 
Relative expression lgfbp1

Relative expression Ppargc1a
Relative expression lrs2
Relative expression Pck1
Relative expression Pck1
Relative expression Hmgcs
Relative expression Srebf1 Relative expression G6pc
Relative expression G6pc
Glucose 
Relative expression lgfbp1
Relative expression Ppargc1a
Relative expression Pck1
Relative expression Hmgcr
Relative expression Hmgcs
Relative expression Srebf1
Relative expression Gck Relative expression G6pc Irs1 -/-; Irs2 -/-; Foxo1 -/-livers shows that livers lacking both Foxo1 and much of the proximal insulin signaling pathway are capable of mounting a normal transcriptional response to nutritional intake. The restoration of normal regulation of metabolic responses in the TLKO liver raised two key questions: (i) does the appropriate postprandial response in livers null for both Akt and Foxo1 reflect a reestablishment of insulin action?; and (ii) are the changes in gene expression in TLKO mice accompanied by a corresponding suppression of hepatic glucose output? To dissociate the effects of insulin from those of nutrients on gene expression, we measured the levels of mRNA encoding key regulatory proteins in control and TLKO livers during euglycemic clamp with and without infusion of insulin. As shown in Figure 5d , expression of both G6pc and Pck1 was suppressed by insulin to the same extent in the TLKO livers as in the control livers, indicating that insulin was able to suppress the transcription of these two genes independent of Akt and Foxo1 in the liver. Notably, insulin also suppressed glucose production in the TLKO mice in a manner that was indistinguishable from the control mice, as ascertained by use of the euglycemic clamp (Fig. 5e) . These data further support the permissive role for Akt-dependent inhibition of Foxo1, as normal regulation persists in the absence of both proteins.
The data presented above indicate that Foxo1 exerts a suppressive effect on the postprandial insulin-responsive pathway that signals independent of Akt. To ask whether this alternative pathway is the sole mediator of insulin action or instead exists in parallel to the canonical pathway, we isolated hepatocytes from TLKO livers and tested their response to insulin in vitro. As a comparison, we also tested hepatocytes from Foxo1 -/-livers. As shown in Figure 6 , in both Foxo1 -/-and TLKO primary hepatocytes, the expression of G6pc, Pck1 and Igfbp1 was substantially lower than in control cells and did not respond to the addition of insulin. Thus, when studied ex vivo, Foxo1 -/-and TLKO hepatocytes behaved as if insulin signals were being passed through the canonical linear pathway of Akt-dependent inhibition of Foxo1-driven gluconeogenic gene expression (Fig. 5a) .
DISCUSSION
In this study, we used genetic manipulation of the mouse genome to study the tissue-specific physiological functions of Akt and Foxo1 in insulin-regulated metabolic responses in liver. We established that hepatic Akt is essential for maintaining whole-body glucose homeostasis and insulin responsiveness and that Akt kinases execute these functions primarily through suppressing Foxo1. However, we also made several observations that cannot be explained by the prevalent, long-held model in which insulin regulates glycemia through Akt-dependent suppression of Foxo1-driven metabolic gene expression. First, and most notably, feeding, and to a marked extent insulin alone, suppressed hepatic glucose output and appropriately regulated gene expression in the absence of Akt and Foxo1, indicating that Akt is not an obligate intermediate in insulin's actions to control liver metabolism under some conditions in vivo. This conclusion necessitates a major reevaluation of the current view of how insulin utilizes Akt as a 'downstream' signaling molecule in liver 43 . Second, Foxo1 was activated under both fasting and feeding conditions after loss of Akt in liver, indicating that there was sufficient Akt signaling during fasting to repress a substantial portion of the activity of Foxo1 toward many genes. The functional consequences of this were illustrated by the rather small decreases in blood glucose concentration seen when Foxo1 was deleted from wild-type liver and the greater metabolic changes seen when it was excised from an Akt-deficient liver.
Although about 84% of the Akt protein in liver is the Akt2 isoform, 2LKO mice were almost indistinguishable from control mice in these studies. In contrast, in a previous publication, we reported protection from steatosis in mice with liver-specific deletion of Akt2 and wildtype levels of Akt1 (ref. 44 ). However, there are two key differences in the design of the experiments used in that previous study compared to those of the current study: (i) in the previous study, the metabolic assays focused on lipid synthesis and accumulation, and (ii) we previously ascertained the role of liver Akt2 in obese, insulin-resistant mice. In contrast, when fed with normal chow, insulin-dependent signaling and glucose tolerance were largely the same in 2LKO mice as in wild-type mice, indicating a capacity of residual Akt1 to compensate the loss of Akt2 under these conditions. Consistent with this, the amount of Akt phosphorylation 4 h after feeding was nearly the same in control and 2LKO livers, indicating that only a small fraction of total hepatic Akt was phosphorylated after normal chow feeding, but that this phosphorylation was sufficient to convey insulin signaling. In contrast to 2LKO mice, DLKO mice were hyperglycemic, glucose intolerant and insulin resistant. These phenotypes are similar to those produced by liver-specific insulinreceptor knockout 5 and liver-specific Irs1 and Irs2 double knockout 6 . Hyperglycemia in the DLKO mice was milder than that in the other two insulin-signaling-deficient models, although this result might have been caused by the acute deletion of Akt1 and Akt2 from the livers of DLKO mice rather than Cre-dependent recombination early in life, which would enhance the development of secondary peripheral insulin resistance. The similar phenotypes between the liver-specific Irs1 -/-; Irs2 -/-doubleknockout mice and the DLKO mice suggest that the signaling is linear between the Irs and Akt nodes without any major branch points.
In TLKO livers, despite the lack of Akt and Foxo1, the liver adapted appropriately to the fed state, successfully modulating its gene expression and maintaining euglycemia. This appropriate regulation in these mice indicates that there is a pathway independent of Akt and Foxo1 that signals the liver's adaptation to feeding. This parallel pathway may have been partially functional even in the DLKO livers, as expression of some genes, such as Ppargc1a, Igfbp1 and Srebf1, responded to feeding; however, many more genes lost regulation in DLKO livers and then regained it in the TLKO livers. Perhaps most notably, in TLKO mice, insulin suppressed hepatic glucose production in a manner that was indistinguishable from that in control mice. These results show that Akt is not required for insulin to regulate hepatic metabolism under all conditions and, thus, the kinase is not an obligate intermediate in a simple, linear pathway. However, the disrupted glucose metabolism and substantial insulin resistance seen in the DLKO livers indicate that under normal conditions, Akt is indispensable to the preservation of metabolic homeostasis. Furthermore, normalization of the metabolic npg a r t i c l e s disturbances present in the DLKO liver by additional deletion of Foxo1 argues that the predominant role of Akt is to suppress Foxo1.
To reconcile these seemingly conflicting data, we propose that active Foxo1 exerts a general repressive effect on many of the early physiological adaptations to feeding (Supplementary Fig. 11 ). We suggest that Akt participates in the liver's response to postprandial insulin and nutrient abundance by maintaining the suppression of Foxo1 activity, thus allowing the full prandial response. Notably, even during the fasting state, a repressive function of Akt toward Foxo1 is still largely operational, such that the changes in Foxo1 activity that accompany normal physiological fluctuations in insulin concentrations are rather modest. We propose that Akt maintains a persistent suppressive effect on a large fraction of Foxo1 protein throughout routine daily periods of fasting and feeding.
Though this interpretation is a departure from the traditional model of insulin action, it is nonetheless consistent with a substantial body of relevant published data as well as the results presented here. As discussed above, expression of Foxo1 target genes in response to a change in metabolic state can occur in the absence of both Akt and Foxo1. In addition, there appear to be major differences in the impact of Foxo1 deletion in normal compared to insulin-resistant livers. In mice not stressed by insulin resistance, acute deletion of Foxo1 does not reduce the expression of Foxo1 target genes, although chronic deletion of multiple Foxo family members, including Foxo1, results in a modest reduction in the expression of these genes 30, 31 . In contrast, in this and previous reports 6, 30 , the effects of Foxo1 deletion on the expression of these genes are more marked in mice with insulin resistance than in wild-type mice, whether induced genetically or by nutritional overabundance, and the scope of Foxo1 deletion is broader in these mice, affecting not only the gluconeogenic program but many anabolic programs as well. In fact, many of the studies that have supported a major role for Foxo1 in the control of glucose homeostasis were performed in mouse models of insulin resistance 22, 32, 33 or by overexpressing a gain-of-function Foxo1 mutant 27 . Even in model organisms such as Caenorhabditis elegans and Drosophila melanogaster, the functional importance of Foxo orthologs has been best revealed on genetic backgrounds with defective insulin signaling [45] [46] [47] . These data are compatible with the idea that Foxo1 becomes active during insulin resistance but is largely repressed in normal mice.
At present, it is unclear how Akt exerts a repressive effect on Foxo1 during fasting. The established mechanism by which Akt directly inhibits Foxo1 involves its phosphorylation at Thr24, Ser253 and Ser316 of the mouse protein by Akt. Both feeding and insulin injection in fasted mice induced Foxo1 phosphorylation at these sites, indicating that the majority of Foxo1 is not phosphorylated during fasting and, therefore, phosphorylation of Foxo1 cannot be used to explain the Akt-dependent repression of Foxo1 during fasting. Foxo1 is phosphorylated at sites in addition to those mentioned above, and its activity is modulated through acetylation 38 , methylation 48 , glycosylation 49 and ubiquitination 50 . It remains to be determined whether Akt affects Foxo1 activity through these modifications or through a cofactor that functions cooperatively with Foxo1 (ref. 51) .
One trivial possibility that could be raised to explain the lack of a major effect of deletion of Foxo1 on fasting metabolism is functional rescue by other Foxo family members. This is unlikely for several reasons. First, there is little enhancement of fasting hypoglycemia in liverspecific Foxo1-null mice when additional Foxo family members are deleted 31 . Second, if Foxo family members other than Foxo1 are capable of transmitting a signal to induce gluconeogenic gene expression and to enhance hepatic glucose output, then deletion of Foxo1 alone would be unable to suppress the abnormalities incurred by the removal of Akt1 and Akt2 from liver. In this study, we found a more profound effect of deletion of Foxo1 alone in the liver on fasting glycemia than has been reported previously 30 , possibly resulting from the acute nature of the recombination in our protocol. Of note, the hypoglycemia in the liver-specific Foxo1 knockout was reversed by concomitant deletion of Akt. These data suggest that the phenotypes in the liver-specific Foxo1-deletion mice depended on the presence of functional Akt, although the underlying mechanism for this is not clear.
A major question to be addressed in future studies is the nature of the regulatory signal(s) triggered by feeding that are suppressed by the unrestrained activity of Foxo1 (Supplementary Fig. 11 ). As mice with liver-specific knockout of Irs1 and Irs2 show a pattern of gene expression similar to that of DLKO mice 6 , including their normalization by the concomitant deletion of Foxo1, it is probable that any Akt-independent, cell-autonomous pathway for the control of hepatic metabolism is not signaled through the Irs proteins. In addition, the loss of phosphorylation of recognized Akt substrates in DLKO and TLKO livers argues strongly against the idea that Akt-like kinases rescue insulin signaling under these conditions. These data are consistent with the requirement for Foxo1 for insulin regulation of gene expression in primary hepatocytes, a result that contrasts sharply with the relatively normal insulin action seen in TLKO livers in vivo. Taken together, these data suggest strongly that insulin's regulation of hepatic function in TLKO mice is not cell autonomous, meaning that the direct insulin target organ is not the liver. Thus, it is probable that the canonical Akt-Foxo pathway operates in a cell-autonomous manner in response to insulin and that there is a parallel pathway in which insulin signals to the liver through another intermediary tissue. Consistent with the idea of non-cell-autonomous regulation of hepatic metabolism, the restoration of hepatic insulin signaling alone is not sufficient to reverse the diabetic phenotype associated with systemic loss of the insulin receptor 52 . One candidate target organ for insulin is the central nervous system, as a number of studies have provided data supporting a role of insulin signaling through the brain to control hepatic glucose output [52] [53] [54] [55] [56] . It will be of great interest to determine conclusively whether the apparent normal suppression of liver glucose production in TLKO livers is mediated through insulin signaling in the liver or, rather, at some other site, such as the brain or adipocytes.
These findings have implications for understanding the pathophysiology of type 2 diabetes mellitus (T2DM) and for potentially designing effective therapeutics for this disorder. Given the substantial evidence cited above that Foxo1 is inappropriately active in mouse models of insulin resistance, the idea has emerged that, like type 1 diabetes mellitus, T2DM resembles a physiological fasting state during periods of nutritional abundance. However, the data presented here reveal that Foxo1 is largely inactive in healthy mice and, thus, the metabolic state of the liver in T2DM represents a true pathological condition. In addition, we predict that adequate suppression of FOXO1 through targeted therapeutics would restore much of the normal metabolic regulation in individuals with T2DM, as shown in a recent mouse study 57 . This strategy has advantages over the current treatments for T2DM, which produce a state mimicking constitutive hyperinsulinemia, with all of the attendant adverse consequences, such as increased lipid synthesis and hyperlipidemia. Lastly, but perhaps most importantly, the finding of an insulin-dependent, Akt-independent pathway for suppressing liver glucose output raises the possibility of new targets for the treatment of hyperglycemia.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/. 
